Skip to main content
Rural Health Information Hub

FDA: Revocation of Two Authorizations of Emergency Use of In Vitro Diagnostic Device for Detection and/or Diagnosis of COVID-19; Availability

Source
Federal Register
Date
Feb 6, 2024
Summary
The Food and Drug Administration has revoked Emergency Use Authorizations issued to Southern California Permanente Medical Group and Drexel University College of Medicine related to COVID-19 detection and diagnosis tests.
Tagged as
COVID-19 · Legislation and regulations · Pharmacy and prescription drugs